EIF2AK3 and diabetic kidney disease: HG induces a decline in the MFN2‐PERK interaction, suggesting that the MFN2‐PERK signaling pathway may serve as a novel therapeutic target to prevent podocyte injury in DKD (Cao et al., 2021).